BlueYard Capital – Medium

BlueYard Capital

BlueYard Capital

·

Jun 23

Join Our Team as an Investor

“Whether it is to be utopia or oblivion will be a touch-and-go relay race right up to the final moment.” — R. Buckminster Fuller

Join Our Team as an Investor

BlueYard Capital

·

Mar 12

Will geopolitics cause AI agents to compete with locals for Portuguese Real Estate?

… and other musings from our Risk Club Dinner in Lisbon we hosted in partnership with Ricardo Sequerra Amram at Point Nine Capital.

Will geopolitics cause AI agents to compete with locals for Portuguese Real Estate?

BlueYard Capital

·

Feb 27

What happens when 400 autonomous cars can do the work of 10,000 human drivers?

And more ideas from our latest Risk Club series dinner in Berlin

What happens when 400 autonomous cars can do the work of 10,000 human drivers?

BlueYard Capital

·

Feb 25

The Utopia vs. Oblivion Summit

The world feels full of potential, yet completely off its axis. The band of possible outcomes has widened, and the margin for error is…

The Utopia vs. Oblivion Summit

BlueYard Capital

·

Feb 20

Risks and Opportunities in a Multipolar World

Key takeaways from behind closed-doors conversations at the Munich Security Conference

Risks and Opportunities in a Multipolar World

BlueYard Capital

·

Dec 30, 2025

BlueYard Capital 2025: Strides Towards Utopia, Holding the Line against Oblivion

American architect Buckminster Fuller once wrote, “Whether it is to be utopia or oblivion will be a touch-and-go relay race right up to the…

BlueYard Capital 2025: Strides Towards Utopia, Holding the Line against Oblivion

BlueYard Capital

·

Dec 18, 2025

BlueYard leads ZeroPhase’s €5.8M seed

Resilient communication for unmanned defense systems, built and battle-tested in Ukraine

BlueYard Capital

·

Oct 23, 2025

Welcoming Mike Wax to BlueYard as a General Partner

We’re excited to share that Mike Wax has joined BlueYard as a General Partner.

Welcoming Mike Wax to BlueYard as a General Partner

BlueYard Capital

·

Oct 2, 2025

Aerska: $21M Seed to Unlock RNAi Delivery to the Brain

Today, Aerska announced a $21M seed round to develop RNA interference (RNAi) therapies with a novel delivery platform designed to cross the…

Aerska: $21M Seed to Unlock RNAi Delivery to the Brain

BlueYard Capital

·

Sep 25, 2025

Cooling the Future of Compute: Our Investment in Corintis

Today we’re proud to share that BlueYard led the $24M Series A for Corintis, a Swiss startup reshaping how chips are cooled at the most…

Cooling the Future of Compute: Our Investment in Corintis

BlueYard Capital

BlueYard Capital

At BlueYard we invest in only two kinds of technologies: those that move us towards utopia, and those that hold the line against oblivion.

Following

Help

Status

About

Careers

Press

Blog

Store

Privacy

Rules

Terms

Text to speech